ArticleOncotarget2014
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer.
Francesca Lovat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it